LU; Yuefeng

Patent Applications and Registrations

Patent applications and USPTO patent grants for LU; Yuefeng.The latest application filed is for "il-2 fusion proteins that preferentially bind il-2ralpha".

Company Profile

9.7.20

LU; Yuefeng - Moorpark CA
Lu; Yuefeng - Newbury Park CA
Lu; Yuefeng - North York CA
Lu, Yuefeng - San Carlos CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Il-2 Fusion Proteins That Preferentially Bind Il-2ralpha App 20220306714 - YAO; Chen ; et al.	2022-09-29
Novel Il-21 Prodrugs And Methods Of Use Thereof App 20220289822 - LU; Yuefeng ; et al.	2022-09-15
Novel Angiopoietin 2, Vegf Dual Antagonists App 20220041705 - Lu; Yuefeng ; et al.	2022-02-10
Novel Cytokine Prodrugs App 20210260163 - YU; Chunxiao ; et al.	2021-08-26
Angiopoietin 2, VEGF dual antagonists Grant 11,059,885 - Lu , et al. July 13, 2	2021-07-13
Novel IL-21 Prodrugs and Methods of Use Thereof App 20210163562 - LU; Yuefeng ; et al.	2021-06-03
Novel Il-15 Prodrugs And Methods Of Use Thereof App 20200392235 - LU; Yuefeng ; et al.	2020-12-17
Angiopoietin 2, VEGF dual antagonists Grant 10,654,922 - Lu , et al.	2020-05-19
Motion-adaptive intra-refresh for high-efficiency, low-delay video coding Grant 10,652,572 - Lu , et al.	2020-05-12
Novel Angiopoietin 2, VEGF Dual Antagonists App 20200131260 - Lu; Yuefeng ; et al.	2020-04-30
Novel Angiopoietin 2, Vegf Dual Antagonists App 20200102381 - Lu; Yuefeng ; et al.	2020-04-02
Novel Antibodies And Methods For Making And Using The Same App 20200040101 - Lu; Yuefeng ; et al.	2020-02-06
Novel Feline Erythropoietin Receptor Agonists App 20190248858 - Lu; Jian-Feng ; et al.	2019-08-15
Feline erythropoietin receptor agonists Grant 10,287,336 - Lu , et al.	2019-05-14
PD-L1 Specific Monoclonal Antibodies for Disease Treatment and Diagnosis App 20190106494 - Wang; Aijun ; et al.	2019-04-11
PD-L1 specific monoclonal antibodies for disease treatment and diagnosis Grant 10,077,308 - Wang , et al. September 18, 2	2018-09-18
Novel Antibody-albumin-drug Conjugates (aadc) And Methods For Using Them App 20180055944 - Lu; Yuefeng ; et al.	2018-03-01
Fusion Protein Comprising Leptin and Methods for Producing and Using the Same App 20180009869 - Lu; Yuefeng ; et al.	2018-01-11
PD-L1 Specific Monoclonal Antibodies for Disease Treatment and Diagnosis App 20170355770 - Wang; Aijun ; et al.	2017-12-14
Novel Angiopoietin 2, VEGF Dual Antagonists App 20170327569 - Lu; Yuefeng ; et al.	2017-11-16
Motion-adaptive Intra-refresh For High-efficiency, Low-delay Video Coding App 20170318308 - Lu; Yuefeng ; et al.	2017-11-02
Fusion Proteins With Dual Receptor Agonist Activities App 20160137712 - Lu; Yuefeng ; et al.	2016-05-19
Novel Feline Erythropoietin Receptor Agonists App 20160083444 - Lu; Jian-Feng ; et al.	2016-03-24
Methods for refolding of recombinant antibodies Grant 7,928,205 - Dillon , et al. April 19, 2	2011-04-19
Methods for refolding of recombinant antibodies App 20060194280 - Dillon; Thomas ; et al.	2006-08-31
Antiviral compounds and method of treating viral infections App 20020111382 - Cui, Xiangmin ; et al.	2002-08-15
Bee venom protein and gene encoding same Grant 6,395,306 - Cui , et al. May 28, 2	2002-05-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.